Enovis Corporation
ENOV
$0.29 (-1.20%)
1D
1W
3M
1Y
5Y
ALL
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment develops, manufactures, and distributes rigid bracing products, orthopedic soft goods, vascular systems and compression garments, and hot and cold therapy products and offers recovery sciences products in the clinical rehabilitation and sports medicine markets, such as bone growth stimulators and electrical stimulators used for pain management. The Reconstructive segment develops, manufactures, and markets a variety of knee, hip, shoulder, elbow, foot, ankle, and finger implant products and surgical productivity tools. It also provides Novastep, a minimally invasive surgery (MIS) foot and ankle solutions.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 10 days ago • ENOV
Royce Small-Cap Fund FY 2025: What Worked
Zacks Investment Research • 14 days ago • ENOV
Wall Street Analysts Think Enovis (ENOV) Could Surge 76.62%: Read This Before Placing a Bet
Seeking Alpha • 20 days ago • ENOV
Enovis Corporation (ENOV) Q4 2025 Earnings Call Transcript
Zacks Investment Research • 21 days ago • ENOV
Enovis (ENOV) Q4 Earnings Beat Estimates
GlobeNewsWire • 21 days ago • ENOV
Update: Enovis Announces Fourth Quarter and Full Year 2025 Results
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.